|
skos:pref |
"Dyslipidemia"@en
|
|
schema:main |
<https:/ |
|
<http:/ |
|
|
skos:editorial |
"Coëlho - Zakwoordenboek der geneeskunde"@nl |
| "Veranderd gehalte aan lipiden in het bloedserum"@nl | |
| "Dyslipidemia / M.J. van Dam"@nl | |
|
skos:in |
<http:/ |
Inverse relations
[ .. ] → schema:about → Dyslipidemia
De novo apoA-I production : regulation and nutritional effects / Stefan Philomina Joseph Dullensschema:ProductModel
Dyslipidemia, sense, antisense or nonsense? / door Maartje Elisabeth Visserschema:ProductModel
Dyslipidemia, sense, antisense or nonsense? / Maartje Elisabeth Visserschema:ProductModel
Dyslipidemia; diagnosis and treatment / Maria Jella van Damschema:ProductModel
Dyslipidemia; diagnosis and treatment / Maria Jella van Damschema:ProductModel
Novel insights into FXR actions in liver and intestine / Marije Boesjesschema:ProductModel
Novel insights into FXR actions in liver and intestine / Marije Boesjesschema:ProductModel
Novel mechanisms for prevention and treatment of type 2 diabetes / Naishi Lischema:ProductModel
Novel mechanisms for prevention and treatment of type 2 diabetes / Naishi Lischema:ProductModel
Statin therapy in diabetic dyslipidemia : efficacy and mechanisms / Ingrid Ingeborg Louise Berk-Plankenschema:ProductModel
The dyslipidemia of chronic renal failure and the effects of statin therapy / Riza Cemil Özsoyschema:ProductModel
The dyslipidemia of chronic renal failure and the effects of statin therapy / Riza Cemil Özsoyschema:ProductModel
The role of hepatic inflammation in the development of hepatic steatosis and insulin resistance / Anouk Funkeschema:ProductModel
The role of hepatic inflammation in the development of hepatic steatosis and insulin resistance / Anouk Funkeschema:ProductModel